Diseases Market Research

Reportbuyer.com helps you stay ahead with advanced reports on Diseases. Information includes Competitive Positioning, Stakeholder Opinions and Future Market Watch.

Stay up-to-date with new products added to this category

Results 301 - 400 of 433 go to 1st page

first

previous 1 2 3 4 5 next

last

Title	Date	Price
Pipeline And Commercial Insight: Parkinson's Disease Market To Grow As First Round Of Lifecycle Management Strategies Succeed	Sep 2007	£7,600
The Global Pain Pharmaceutical Market Analysis & Forecasts 2007-2022	Sep 2007	£1,499
Pipeline Insight: Neuropathic Pain Emerging Drugs Fail To Capitalize In Lucrative Market	Sep 2007	£6,000
Commercial Insight: Migraine Opportunities Will Exist In The Wake Of Generic Attack	Sep 2007	£7,600
Commercial Insight: Epilepsy Companies Committed To The Cause Will Reap The Benefits	Sep 2007	£7,600
Pipeline Insight: Antidiabetics - Insulins	Sep 2007	£5,785
Decoding Big Pharmas R&D Strategy in Oncology	Sep 2007	£3,360
Cancer Vaccine Developments to 2013	Sep 2007	£1,296
Innovations in Cardiovascular Disease Management: Latest surgical procedures, drugs and medical devices	Sep 2007	£1,730
Chinese Markets for HIV Treatment Drugs	Sep 2007	£2,405
Global Hepatitis Strategies	Aug 2007	£2,400
Cardiovascular Pharmaceutical Market Trends, 2007 to 2010 Key market forecasts and growth opportunities	Aug 2007	£895
Commercial Insight: Asthma & COPD - Combination products still have blockbuster potential	Jul 2007	£9,140
Commercial Insight: HIV - Reshaping Treatment Paradigms	Jul 2007	£9,140
Melanoma - Targeted Therapeutics	Jul 2007	£1,425
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Melanoma and NSCLC	Jul 2007	£2,525
Disease Management and Drug Adherence: Strategies to support patients and enhance treatment persistence	Jul 2007	£4,570
Stakeholder Opinions: Primary Brain Cancer	Jul 2007	£2,280
Commercial Insight: Top 20 Cancer Therapy Brands - Sales of targeted therapies overtake cytotoxics in 2006	Jul 2007	£9,140
Innovative And Targeted Cancer Therapies Key Technologies, New Applications And Leading Players	Jul 2007	£1,495
The Global HIV/Aids Market Outlook To 2012	Jul 2007	£1,495
Commercial Insight: Depression Atypical lifecycle management strategy rejuvenates depression market	Jun 2007	£9,140
Commercial Insight: Osteoporosis Risk management and reformulation offer best defense against generic onslaught	Jun 2007	£9,140
CNS Market Trends, 2007 to 2010 Key Market Forecasts and Growth Opportunities	Jun 2007	£995
Stakeholder Opinions: Irritable Bowel Syndrome Potentially profitable market is open for the taking	Jun 2007	£2,285
Neurodegenerative Disease Drug Market Analysis and Forecasts 2007	Jun 2007	£1,999
Stakeholder Opinions: Hepatocellular Carcinoma Opportune indication for novel therapies	Jun 2007	£2,280
China Anti-tumor Drugs Market Report 2007	Jun 2007	£180
Antibody Drug Target Atlas in Oncology	Jun 2007	£1,790
Stakeholder Opinions: Female Sexual Dysfunction Results from Datamonitor's 2005 physician survey	Jun 2007	£2,280
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Breast- and Prostate Cancer	Jun 2007	£2,525
Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Focus on Leukemias and Lymphomas	Jun 2007	£2,525
Global Tuberculosis Strategies	Jun 2007	£2,400
Multiple Sclerosis World Market Outlook to 2011	Jun 2007	£1,800
Analytical Tool - Hematological Cancers	May 2007	£5,440
Analytical Tool - Analysis of Cancer Immunotherapy The World Guide	May 2007	£4,525
Analytical Tool - Current & Future Lung Cancer Therapeutics	May 2007	£2,835
Analytical Tool - Leukemia Therapeutics & Competitive Insights	May 2007	£2,835
Analytical Tool - Lymphoma Therapeutics & Competitive Insights	May 2007	£2,835
Cancer Drug Discoveries: Prostate Cancer	May 2007	£795
Cancer Drug Discoveries What the Future Holds	May 2007	£2,995
Pharma Sales Force Effectiveness: Increasing Productivity Through Streamlined Internal Communication	May 2007	£3,015
Global Cancer Focus Company Directory	Apr 2007	£1,425
Targeted Therapeutics in Non-Small Cell Lung Cancer	Apr 2007	£1,425
Non-Small Cell Lung Cancer Drug Pipeline Update 2007	Apr 2007	£1,370
Stakeholder Opinions: Asthma Phenotypes A changing paradigm	Mar 2007	£2,280
Pipeline Insight: Depression Novel drugs to grow third-line market	Mar 2007	£6,855
GSK's Cervarix A Future Blockbuster of 2007	Mar 2007	£1,999
Stakeholder Opinions: Nosocomial Infections The need for new gram-negative drugs	Mar 2007	£2,280
Stakeholder Opinion: Atopic Dermatitis A high level of unmet need creates market opportunities	Mar 2007	£2,280
AMD Market Outlook to 2012	Mar 2007	£1,299
Stakeholder Opinions: Small Cell Lung Cancer and Malignant Mesothelioma Limited R&D activity provides opportunity for early-phase pipeline drugs	Mar 2007	£2,280
Global Pipeline Review & Analysis of Hematological Malignancies	Mar 2007	£2,155
Prostate and Breast Cancer New Treatments & Developmental Progress	Mar 2007	£2,155
Diabetes and Diabetic Complications Major World Markets, 3rd Ed.	Mar 2007	£2,400
The Autoimmune Inflammatory Bowel Disease Market Outlook to 2012	Feb 2007	£1,499
Breast Cancer Therapeutic And Competitive Insights	Feb 2007	£1,425
Innovations in Cancer Novel Therapeutics, New Diagnostics and Future R&D Strategies	Feb 2007	£1,730
Cancer Therapeutics: The Worldwide Market The Worldwide Market , 2nd Editon	Feb 2007	£2,400
Disease Management Dimensions	Feb 2007	£480
The Global Market for Pain Management Drugs and Devices	Jan 2007	£2,915
Immunotherapy of Cancer	Jan 2007	£2,915
Drug Treatments for Leading Endocrine and Metabolic Diseases	Jan 2007	£2,915
Innovations in CNS Novel therapeutics and future R&D strategies	Jan 2007	£1,730
The Cardiovascular Market Outlook to 2011	Jan 2007	£1,730
Commercial Insight: HIV Change of guard	Dec 2006	£7,955
Stakeholder Opinion: Erectile Dysfunction Identifying product differentiation and patient segmentation strategies	Dec 2006	£2,280
Commercial Insight: Osteoarthritis Market sees steady growth	Dec 2006	£7,955
Stakeholder Opinions: Respiratory Syncytial Virus (RSV) A market yet to reach its full potential	Dec 2006	£2,280
Stakeholder Insight: Multiple Sclerosis Disease-modifying efficacy and side effects guide treatment choice	Dec 2006	£7,955
Stakeholder Insight: Atherosclerosis HDL, ApoA-I, Carotid MRI and 64-slice CT offer opportunities for future treatment	Dec 2006	£7,955
Commercial and Pipeline Insight: Psoriasis Anti-TNF's lead another indication	Dec 2006	£7,955
Pipeline Insight: Therapeutic Cancer Vaccines A turbulent path from bench to bedside	Dec 2006	£6,855
Commercial and Pipeline Perspectives: Obesity Lack of Reimbursement Limits Market Potential	Dec 2006	£6,855
Stakeholder Insight: Alzheimer's Disease Prescribing trends indicate that neurologists are not adhering to guidelines	Dec 2006	£7,955
Commercial Insight: Antibacterials Growth in resistance rates drives niche indications	Dec 2006	£7,955
Pipeline Insight: Migraine Innovation essential as weak late-stage pipeline fails to hold off the impact of triptan patent expiries	Dec 2006	£6,855
Stakeholder Insight: Pricing and Reimbursement in Oncology Do payers believe oncology drugs offer good value?	Dec 2006	£6,855
Stakeholder Opinions: Gynecological Cancers Niche opportunities in advanced disease	Dec 2006	£2,280
World Market for Pain Management Drugs and Devices 2nd Edition	Dec 2006	£2,105
Triple Analysis: Apoptosis Agents, Protein Kinase Inhibitors and Anti-Angiogenic Agents in Oncology	Dec 2006	£4,730
Preclinical Cancer Therapeutics 2007 Decoding Next Generation Drug Targets for Market Success	Dec 2006	£1,600
CNS Drug Discoveries: Neurodegenerative Disorders	Nov 2006	£795
Stakeholder Insight: Respiratory Tract Infections in the USA The demise of narrow-spectrum antibiotics	Nov 2006	£7,955
CNS Drug Discoveries: Attention Deficit Hyperactivity Disorder (ADHD)	Nov 2006	£795
Pipeline Insight: Breakthrough Pain Fast-acting players will capture majority market share	Nov 2006	£6,855
Pipeline Insight: Osteoarthritis The Wait for a DMOAD Continues	Nov 2006	£6,855
Regulator Perceptions in Cancer Evolving opinions about the oncology drug approval process	Nov 2006	£1,140
Emerging Cancer Vaccine Market, The 2nd Edition	Nov 2006	£2,105
Pipeline Insight: Epilepsy Pipeline drugs struggle to outshine their marketed predecessors	Oct 2006	£6,855
Pipeline/Commercial Insight: Colorectal Cancer Shaping the future dynamics of colorectal cancer management	Oct 2006	£7,955
Pipeline/Commercial Insight: Molecular Targeted Cancer Therapies More drugs on the market, more targets in the pipeline	Oct 2006	£7,955
Stakeholder Insight: Atrial Fibrillation Limited efficacy and poor safety lead to bleak outlook	Oct 2006	£7,955
Stakeholder Insight: Supportive Care in Cancer Treatment Some first-generation products proving difficult to dislodge	Oct 2006	£7,955
Rheumatoid Arthritis: Market Trends and R&D Insights	Sep 2006	£750
Advanced Life Sciences' Cethromycin Phase III success should allow 'me-too' market entry and above-consensus growth	Sep 2006	£2,280
Pipeline Insight: Insulins Inhalable insulins unlikely to become blockbusters	Sep 2006	£6,855
Commercial Insight: Antihypertensives New challenges for a maturing market	Sep 2006	£7,955
Psoriasis and Psoriatic Arthritis A Strategic Analysis of the Market in the United States	Sep 2006	£2,105